Skip to main content
Creo Medical Group PLC (BST:1RC)
Germany flag Germany · Delayed Price · Currency is EUR
0.135
0.00 (0.00%)
At close: Apr 28, 2026

Creo Medical Group Statistics

Total Valuation

BST:1RC has a market cap or net worth of EUR 56.29 million. The enterprise value is 37.49 million.

Market Cap 56.29M
Enterprise Value 37.49M

Important Dates

The next estimated earnings date is Wednesday, May 13, 2026.

Earnings Date May 13, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 402.47M
Shares Outstanding n/a
Shares Change (YoY) +17.86%
Shares Change (QoQ) n/a
Owned by Insiders (%) 3.58%
Owned by Institutions (%) 86.80%
Float 364.20M

Valuation Ratios

The trailing PE ratio is 96.50.

PE Ratio 96.50
Forward PE n/a
PS Ratio 10.49
PB Ratio 0.79
P/TBV Ratio 0.80
P/FCF Ratio 6.89
P/OCF Ratio 7.10
PEG Ratio n/a

Enterprise Valuation

EV / Earnings 64.27
EV / Sales 7.07
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF 4.59

Financial Position

The company has a current ratio of 5.28, with a Debt / Equity ratio of 0.07.

Current Ratio 5.28
Quick Ratio 4.47
Debt / Equity 0.07
Debt / EBITDA n/a
Debt / FCF 0.60
Interest Coverage -57.50

Financial Efficiency

Return on equity (ROE) is 4.80% and return on invested capital (ROIC) is -51.57%.

Return on Equity (ROE) 4.80%
Return on Assets (ROA) -20.82%
Return on Invested Capital (ROIC) -51.57%
Return on Capital Employed (ROCE) -36.62%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 41,600
Profits Per Employee 4,522
Employee Count 129
Asset Turnover 0.07
Inventory Turnover 0.43

Taxes

Income Tax -816,619
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +28.57% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +28.57%
50-Day Moving Average 0.15
200-Day Moving Average 0.14
Relative Strength Index (RSI) 46.96
Average Volume (20 Days) n/a

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, BST:1RC had revenue of EUR 5.37 million and earned 583,299 in profits.

Revenue 5.37M
Gross Profit 2.45M
Operating Income -26.83M
Pretax Income 2.22M
Net Income 583,299
EBITDA -27.18M
EBIT -26.83M
Earnings Per Share (EPS) -0.00

Balance Sheet

The company has 23.92 million in cash and 4.90 million in debt, giving a net cash position of 19.02 million.

Cash & Cash Equivalents 23.92M
Total Debt 4.90M
Net Cash 19.02M
Net Cash Per Share n/a
Equity (Book Value) 71.05M
Book Value Per Share 0.17
Working Capital 29.98M

Cash Flow

In the last 12 months, operating cash flow was 7.93 million and capital expenditures 233,320, giving a free cash flow of 8.17 million.

Operating Cash Flow 7.93M
Capital Expenditures 233,320
Depreciation & Amortization -346,044
Net Borrowing -1.04M
Free Cash Flow 8.17M
FCF Per Share n/a

Margins

Gross margin is 45.65%, with operating and profit margins of -500.00% and 10.87%.

Gross Margin 45.65%
Operating Margin -500.00%
Pretax Margin 41.30%
Profit Margin 10.87%
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin 152.17%

Dividends & Yields

BST:1RC does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -17.86%
Shareholder Yield -17.86%
Earnings Yield 1.04%
FCF Yield 14.51%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

BST:1RC has an Altman Z-Score of 1.76 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.76
Piotroski F-Score 5